ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 91 filers reported holding ADICET BIO INC in Q1 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $441,351 | -57.8% | 181,626 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1,046,166 | -35.6% | 181,626 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $1,623,736 | -37.1% | 181,626 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $2,583,000 | -2.6% | 181,626 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,651,000 | -26.9% | 181,626 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,627,000 | +14.2% | 181,626 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $3,176,000 | +123.0% | 181,626 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $1,424,000 | -23.8% | 181,626 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,869,000 | -21.3% | 181,626 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,375,000 | -6.9% | 181,626 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,552,000 | +18.2% | 181,626 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,159,000 | – | 181,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |